316 related articles for article (PubMed ID: 31434983)
81. Kynurenine-3-monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression.
Chen Y; Zhang J; Yang Y; Xiang K; Li H; Sun D; Chen L
J Cell Physiol; 2022 Dec; 237(12):4339-4355. PubMed ID: 36088660
[TBL] [Abstract][Full Text] [Related]
82. HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway.
Wang B; Lian YJ; Su WJ; Peng W; Dong X; Liu LL; Gong H; Zhang T; Jiang CL; Wang YX
Brain Behav Immun; 2018 Aug; 72():51-60. PubMed ID: 29195782
[TBL] [Abstract][Full Text] [Related]
83. Kynurenine inhibits melanogenesis in human melanocyte-keratinocyte co-cultures and in a reconstructed 3D skin model.
Ferreira Branquinho MS; Silva MBB; Castilho GA; Cavalcante J; Barros SBM; Clara RO; Maria-Engler SS; Campa A
Exp Dermatol; 2022 Mar; 31(3):427-432. PubMed ID: 34710259
[TBL] [Abstract][Full Text] [Related]
84. Inhibition of the kynurenine pathway protects against reactive microglial-associated reductions in the complexity of primary cortical neurons.
O'Farrell K; Fagan E; Connor TJ; Harkin A
Eur J Pharmacol; 2017 Sep; 810():163-173. PubMed ID: 28688912
[TBL] [Abstract][Full Text] [Related]
85. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
86. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy.
Ryan KM; Allers KA; McLoughlin DM; Harkin A
Brain Behav Immun; 2020 Jan; 83():153-162. PubMed ID: 31606477
[TBL] [Abstract][Full Text] [Related]
87. Kynurenine pathway in Parkinson's disease-An update.
Venkatesan D; Iyer M; Narayanasamy A; Siva K; Vellingiri B
eNeurologicalSci; 2020 Dec; 21():100270. PubMed ID: 33134567
[TBL] [Abstract][Full Text] [Related]
88. PPARs and the Kynurenine Pathway in Melanoma-Potential Biological Interactions.
Walczak K; Gerkowicz A; Krasowska D
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834531
[TBL] [Abstract][Full Text] [Related]
89. Streptococcal Pyrogenic Exotoxin A-Stimulated Monocytes Mediate Regulatory T-Cell Accumulation through PD-L1 and Kynurenine.
Giesbrecht K; Förmer S; Sähr A; Heeg K; Hildebrand D
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412561
[TBL] [Abstract][Full Text] [Related]
90. Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non-Small Cell Lung Cancer.
Bessede A; Peyraud F; Le Moulec S; Cousin S; Cabart M; Chomy F; Rey C; Lara O; Odin O; Nafia I; Guegan JP; Italiano A
Clin Cancer Res; 2023 Dec; 29(23):4883-4893. PubMed ID: 37756581
[TBL] [Abstract][Full Text] [Related]
91. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
[TBL] [Abstract][Full Text] [Related]
92. Tryptophan-kynurenine profile in pediatric autoimmune hepatitis.
Lytton SD; Osiecki M; MałgorzataWoźniak ; Cukrowska B; Wierzbicka A; Goliszek M; Socha P; Janczyk W; Dayanakli D; Abendroth D; Kramp S; Fechner K; Scheper T; Mahler M; Bentow C; Bogdanos D; Fuchs D; Woynarowski M
Immunol Res; 2019 Feb; 67(1):39-47. PubMed ID: 30666511
[TBL] [Abstract][Full Text] [Related]
93. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
[TBL] [Abstract][Full Text] [Related]
94. Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review.
Wells G; Kennedy PT; Dahal LN
Front Immunol; 2021; 12():651687. PubMed ID: 33777052
[No Abstract] [Full Text] [Related]
95. Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated.
Charehjoo A; Majidpoor J; Mortezaee K
Int Immunopharmacol; 2023 May; 118():110032. PubMed ID: 36933494
[TBL] [Abstract][Full Text] [Related]
96. Human renal tubular epithelial cells suppress alloreactive T cell proliferation.
Demmers MW; Korevaar SS; Roemeling-van Rhijn M; van den Bosch TP; Hoogduijn MJ; Betjes MG; Weimar W; Baan CC; Rowshani AT
Clin Exp Immunol; 2015 Mar; 179(3):509-19. PubMed ID: 25310899
[TBL] [Abstract][Full Text] [Related]
97. Tryptophan-kynurenine pathway attenuates β-catenin-dependent pro-parasitic role of STING-TICAM2-IRF3-IDO1 signalosome in Toxoplasma gondii infection.
Majumdar T; Sharma S; Kumar M; Hussain MA; Chauhan N; Kalia I; Sahu AK; Rana VS; Bharti R; Haldar AK; Singh AP; Mazumder S
Cell Death Dis; 2019 Feb; 10(3):161. PubMed ID: 30770800
[TBL] [Abstract][Full Text] [Related]
98. Uveal melanoma expression of indoleamine 2,3-deoxygenase: establishment of an immune privileged environment by tryptophan depletion.
Chen PW; Mellon JK; Mayhew E; Wang S; He YG; Hogan N; Niederkorn JY
Exp Eye Res; 2007 Nov; 85(5):617-25. PubMed ID: 17870068
[TBL] [Abstract][Full Text] [Related]
99. Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis.
Myint AM; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():304-13. PubMed ID: 24184687
[TBL] [Abstract][Full Text] [Related]
100. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation.
Chen W; Liang X; Peterson AJ; Munn DH; Blazar BR
J Immunol; 2008 Oct; 181(8):5396-404. PubMed ID: 18832696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]